Publications by authors named "Daniela Beck"

Claim this Profile
B
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.
Heike Niessner, Tobias Sinnberg, Corinna Kosnopfel, Keiran S M Smalley, Daniela Beck

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.
Heike Niessner, Corinna Kosnopfel, Tobias Sinnberg, Daniela Beck, Kathrin Krieg

Exp Dermatol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.
Heike Niessner, Andrea Forschner, Bernhard Klumpp, Jürgen B Honegger, Maria Witte, Daniela Beck

Cancer Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.
Daniela Beck, Heike Niessner, Keiran S M Smalley, Keith Flaherty, Kim H T Paraiso

Sci Signal· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells.
Heike Niessner, Daniela Beck, Tobias Sinnberg, Konstantinos Lasithiotakis, Evelyn Maczey

J Invest Dermatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis